Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras @NIHVideoCast
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras  @NIHVideoCast
Uploaded March 2023 | Updated November 2026, 4 days ago
Air date: Wednesday, March 8, 2023, 2PM

Description: NIH Director's WALS Lecture [WALS]
Kevan Shokat is a chemist who discovers drugs against some of the most common drivers of human cancers. He is best known for targeting a mutation that drives more than 1 in 10 lung cancers, opening up a new arena of cancer treatment discovery. The target, K-Ras, is the most common driver of cancer, and was considered “undruggable” by most cancer researchers after 40 years of failed attempts to block its function. Dr. Shokat’s discovery of a K-Ras blocker broke through this decades-old barrier and threw open the doors to a new class of cancer treatments. Lecture summary: 1. To understand the chemical, biochemical and cellular challenges to identifying a drug to target K-Ras mutant tumors 2. To learn how to discover drugs which only target oncogenes in cancer cells while sparing signaling in the rest of the body using covalent chemistry. 3. To learn about new approaches for combination therapy in cancer including re-activation of the tumor suppressor p53 and engaging the immune cells to overcome resistance to targeted therapies.


https://cancer.ucsf.edu/people/shokat.kevan


For more information go to oir.nih.gov/wals


Author: Kevan Shokat, Ph.D., University of California, Berkeley

Permanent link: videocast.nih.gov/watch=46070
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-RasYou contain multitudes: Somatic mutation and genomic diversity in human brainCommon Data Elements, Part 3 of 4Coronavirus Activation and Antagonism of Interferon Signaling Pathways: from MHV to SARS-CoV-2A Clinical Perspective on Clinical Research EndpointsAdverse Events Reporting, Part 4 of 4Community Engagement and Community-Based Participatory Research, Part 1 of 3WALS: How Neuromorphic Computing can Help us Understand the BrainMarathons for T Cells: How They Keep on KillingFDA Product Regulations Part 4 of 7SACHRP October 2023WALS: Evolution of the Glutamate Models of Psychosis
NIH VideoCast |

Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER